This review synthesizes pre-clinical and clinical evidence on adiponectin's role in sepsis, examines the complex interplay with obesity, evaluates potential therapeutic strategies targeting adiponectin pathways including adiponectin mimics and GLP-1 receptor agonists, and outlines key future research directions. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.